REGENXBIO, Inc. (RGNX)
8.96
+0.39
(+4.55%)
USD |
NASDAQ |
Mar 16, 12:36
REGENXBIO Total Assets (Quarterly) : 453.03M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Sarepta Therapeutics, Inc. | 3.350B |
| AbbVie, Inc. | 133.96B |
| Replimune Group, Inc. | 333.59M |
| BioMarin Pharmaceutical, Inc. | 7.594B |
| Altimmune, Inc. | 279.93M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 350.30M |
| Shareholders Equity (Quarterly) | 102.73M |
| Debt to Equity Ratio | 2.536 |
| Current Ratio | 2.382 |
| Net Debt Paydown Yield | -3.13% |